Back

De novo mutation rate in patients with hypertrophic cardiomyopathy and left ventricular non-compaction.

26 May 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Comorbidities and cardiomyopathies - How to manage? Genetics, Epigenetics, ncRNA HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor Elena Zaklyazminskaya

Petrovsky National Research Center of Surgery, Moscow (Russian Federation)

12 More presentations in this session

Presentation thumbnail
Microvascular complications in diabetes patients with heart failure and reduced ejection fraction
Doctor S. Kristensen (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
The importance of measuring fractional flow reserve to improve the efficiency of endovascular treatment on left main bifurcation lesions
Associate Professor D. Maximkin (Moscow, RU)
Abstract Slides Video
Presentation thumbnail
Pretreatment with P2Y12 Receptor Antagonists in ST-Elevation Myocardial Infarction: A Report from the Swedish Coronary Angiography and Angioplasty Registry
Professor E. Omerovic (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Characterization of plasmacytoid and myeloid dendritic cells in acute human and experimental myocarditis
Doctor R. Pistulli (Munster, DE)
Abstract
Presentation thumbnail
Ticagelor is not superior to clopidogrel in patients with acute coronary syndrome: A report from SCAAR
Professor E. Omerovic (Gothenburg, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Comorbidities and cardiomyopathies - How to manage?

The Event

Event poster

Heart Failure 2018

26 May - 29 May 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources